News for Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics' VRDN-001 demonstrates rapid efficacy in TED. Read why VRDN stock may benefit from FDA approval and market differentiation.

Viridian Therapeutics (VRDN) delivered earnings and revenue surprises of 22.86% and 17.24%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Viridian Therapeutics Inc (VRDN), a biotechnology firm dedicated to developing innovative treatments for serious and rare diseases, has announced its business h

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines fo

On February 7, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a significant transaction by acquiring 4,210,525 shares of Galapagos NV. This acqu

On December 31, 2024, GREAT POINT PARTNERS LLC (Trades, Portfolio) executed a notable transaction by acquiring 1,381,759 shares of Vistagen Therapeutics Inc at

On December 31, 2024, GREAT POINT PARTNERS LLC (Trades, Portfolio) executed a significant transaction involving Unicycive Therapeutics Inc (UNCY). The firm adde

On December 31, 2024, GREAT POINT PARTNERS LLC (Trades, Portfolio) executed a notable transaction by increasing its holdings in ProMIS Neurosciences Inc. The fi

On December 31, 2024, GREAT POINT PARTNERS LLC (Trades, Portfolio) executed a significant transaction by acquiring an additional 926,972 shares of Outlook Thera

On December 31, 2024, GREAT POINT PARTNERS LLC (Trades, Portfolio) made a strategic move by acquiring an additional 39,176 shares of OptiNose Inc at a price of

On December 31, 2024, GREAT POINT PARTNERS LLC (Trades, Portfolio) made a significant move by reducing its holdings in Context Therapeutics Inc (CNTX). The firm

On December 31, 2024, GREAT POINT PARTNERS LLC (Trades, Portfolio) executed a significant transaction involving Zura Bio Ltd, a biotechnology company. The firm

On December 31, 2024, GREAT POINT PARTNERS LLC (Trades, Portfolio) made a significant move by reducing its stake in Neurogene Inc. The firm decreased its holdin

On December 31, 2024, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a substantial reduction in its holdings of ITeos Therapeutics Inc (ITOS). The fir

Significant Transaction in Cybin Inc On December 31, 2024, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a notable transaction involving Cybin Inc, a

Significant Transaction by Ikarian Capital, LLC (Trades, Portfolio) On December 31, 2024, Ikarian Capital, LLC (Trades, Portfolio) executed a noteworthy transac

Significant Transaction by Ikarian Capital, LLC (Trades, Portfolio) On December 31, 2024, Ikarian Capital, LLC (Trades, Portfolio) executed a noteworthy transac

Significant Transaction by Ikarian Capital, LLC (Trades, Portfolio) On December 31, 2024, Ikarian Capital, LLC (Trades, Portfolio) executed a noteworthy transac

Significant Transaction by Ikarian Capital, LLC (Trades, Portfolio) On December 31, 2024, Ikarian Capital, LLC (Trades, Portfolio) executed a noteworthy transac